KR20170003712A - 위장 장애 치료를 위한 프로스타글란딘 유도체 - Google Patents

위장 장애 치료를 위한 프로스타글란딘 유도체 Download PDF

Info

Publication number
KR20170003712A
KR20170003712A KR1020167036382A KR20167036382A KR20170003712A KR 20170003712 A KR20170003712 A KR 20170003712A KR 1020167036382 A KR1020167036382 A KR 1020167036382A KR 20167036382 A KR20167036382 A KR 20167036382A KR 20170003712 A KR20170003712 A KR 20170003712A
Authority
KR
South Korea
Prior art keywords
compound
constipation
treatment
present
prostaglandin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020167036382A
Other languages
English (en)
Korean (ko)
Inventor
류지 우에노
Original Assignee
수캄포 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35229739&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR20170003712(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 수캄포 아게 filed Critical 수캄포 아게
Publication of KR20170003712A publication Critical patent/KR20170003712A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020167036382A 2004-09-02 2005-09-01 위장 장애 치료를 위한 프로스타글란딘 유도체 Ceased KR20170003712A (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US60652104P 2004-09-02 2004-09-02
US60/606,521 2004-09-02
US66631705P 2005-03-30 2005-03-30
US60/666,317 2005-03-30
US66659305P 2005-03-31 2005-03-31
US60/666,593 2005-03-31
PCT/JP2005/016464 WO2006025599A1 (en) 2004-09-02 2005-09-01 Prostaglandin derivatives for treating gastrointestinal disorder

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020137034994A Division KR20140019006A (ko) 2004-09-02 2005-09-01 위장 장애 치료를 위한 프로스타글란딘 유도체

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020187008381A Division KR20180033310A (ko) 2004-09-02 2005-09-01 위장 장애 치료를 위한 프로스타글란딘 유도체

Publications (1)

Publication Number Publication Date
KR20170003712A true KR20170003712A (ko) 2017-01-09

Family

ID=35229739

Family Applications (4)

Application Number Title Priority Date Filing Date
KR1020167036382A Ceased KR20170003712A (ko) 2004-09-02 2005-09-01 위장 장애 치료를 위한 프로스타글란딘 유도체
KR1020077004900A Ceased KR20070048221A (ko) 2004-09-02 2005-09-01 위장 장애 치료를 위한 프로스타글란딘 유도체
KR1020187008381A Ceased KR20180033310A (ko) 2004-09-02 2005-09-01 위장 장애 치료를 위한 프로스타글란딘 유도체
KR1020137034994A Ceased KR20140019006A (ko) 2004-09-02 2005-09-01 위장 장애 치료를 위한 프로스타글란딘 유도체

Family Applications After (3)

Application Number Title Priority Date Filing Date
KR1020077004900A Ceased KR20070048221A (ko) 2004-09-02 2005-09-01 위장 장애 치료를 위한 프로스타글란딘 유도체
KR1020187008381A Ceased KR20180033310A (ko) 2004-09-02 2005-09-01 위장 장애 치료를 위한 프로스타글란딘 유도체
KR1020137034994A Ceased KR20140019006A (ko) 2004-09-02 2005-09-01 위장 장애 치료를 위한 프로스타글란딘 유도체

Country Status (16)

Country Link
US (2) US8748481B2 (enExample)
EP (1) EP1791545B1 (enExample)
JP (4) JP2008511541A (enExample)
KR (4) KR20170003712A (enExample)
CN (1) CN102885821A (enExample)
AR (1) AR050626A1 (enExample)
AU (1) AU2005278323B2 (enExample)
BR (1) BRPI0514891A (enExample)
CA (1) CA2577284A1 (enExample)
ES (1) ES2603381T3 (enExample)
IL (1) IL181332A (enExample)
MX (1) MX2007002602A (enExample)
NO (1) NO340989B1 (enExample)
NZ (1) NZ553434A (enExample)
TW (1) TWI387454B (enExample)
WO (1) WO2006025599A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004037268A1 (en) * 2002-10-23 2004-05-06 Sucampo Ag Prostaglandin compounds for the treatment of obesity
DE602004030245D1 (de) * 2003-07-03 2011-01-05 Sucampo Ag Pharmazeutische magensaftresistent überzogene zusammensetzung enthaltend prostaglandin-analoga als chloridkanalöffner
CN101466407B (zh) 2006-01-24 2013-05-15 株式会社·R-技术上野 包含双环化合物的药物组合物和使所述双环化合物稳定的方法
US20090030072A1 (en) 2007-07-03 2009-01-29 Sucampo Ag Pharmaceutical combination of opioid and prostaglandin compound
CN108685929A (zh) * 2012-04-23 2018-10-23 苏坎波公司 用于治疗具有腹泻的肠易激综合征的方法
RU2648467C2 (ru) * 2013-02-04 2018-03-26 Тайсо Фармасьютикал Ко., Лтд. Профилактическое или терапевтическое лекарственное средство для лечения запора
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5428062A (en) 1987-01-28 1995-06-27 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
US5166174A (en) 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
US5225439A (en) 1987-01-28 1993-07-06 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
US5317032A (en) * 1987-10-02 1994-05-31 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Prostaglandin cathartic
KR100830061B1 (ko) 1999-10-15 2008-05-16 수캄포 아게 이환식 화합물 조성물 및 이의 안정화 방법
US6414016B1 (en) 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
TWI302100B (en) 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
MXPA03010510A (es) 2001-05-18 2004-03-02 Sucampo Ag Composicion catartica.
MXPA04002006A (es) * 2001-08-31 2004-06-07 Sucampo Ag Analogos de prostagladina como abridor del canal de cloruro.
AR037524A1 (es) * 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
US7732487B2 (en) 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel
MXPA05006981A (es) * 2002-12-27 2005-12-14 Sucampo Ag Derivados de prostaglandinas para el tratamiento de la molestia abdominal.
DE602004030245D1 (de) 2003-07-03 2011-01-05 Sucampo Ag Pharmazeutische magensaftresistent überzogene zusammensetzung enthaltend prostaglandin-analoga als chloridkanalöffner

Also Published As

Publication number Publication date
NZ553434A (en) 2010-01-29
KR20070048221A (ko) 2007-05-08
US20060063830A1 (en) 2006-03-23
ES2603381T3 (es) 2017-02-27
JP2018150354A (ja) 2018-09-27
IL181332A0 (en) 2007-07-04
JP2013049688A (ja) 2013-03-14
KR20140019006A (ko) 2014-02-13
US8748481B2 (en) 2014-06-10
BRPI0514891A (pt) 2008-06-24
AU2005278323B2 (en) 2011-03-17
NO340989B1 (no) 2017-07-31
EP1791545A1 (en) 2007-06-06
EP1791545B1 (en) 2016-08-31
JP2008511541A (ja) 2008-04-17
IL181332A (en) 2015-09-24
AR050626A1 (es) 2006-11-08
CA2577284A1 (en) 2006-03-09
AU2005278323A1 (en) 2006-03-09
NO20071704L (no) 2007-05-31
CN102885821A (zh) 2013-01-23
WO2006025599A1 (en) 2006-03-09
TWI387454B (zh) 2013-03-01
TW200612901A (en) 2006-05-01
KR20180033310A (ko) 2018-04-02
JP6408426B2 (ja) 2018-10-17
JP2015166377A (ja) 2015-09-24
US20140315994A1 (en) 2014-10-23
MX2007002602A (es) 2007-04-25

Similar Documents

Publication Publication Date Title
JP5213448B2 (ja) 末梢血管疾患の処置のための方法および組成物
JP6408426B2 (ja) 胃腸障害処置用プロスタグランジン誘導体
JP2011201905A (ja) 便秘の処置用のプロスタグランジンアナログを含む用量単位
US20090012165A1 (en) Pharmaceutical combination of nsaid and prostaglandin compound
CN1753680B (zh) 用于治疗腹部不适的前列腺素衍生物
RU2392941C2 (ru) Производные простагландинов для лечения желудочно-кишечного нарушения
KR20150065948A (ko) 오피오이드 및 프로스타글란딘 화합물의 약학 조합물
US20130281526A1 (en) Method for treating irritable bowel syndrome with diarrhea
MX2007010746A (es) Metodo y composicion para tratar enfermedades vasculares perifericas.

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20161226

Application number text: 1020137034994

Filing date: 20131230

PG1501 Laying open of application
A201 Request for examination
A302 Request for accelerated examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20170125

Comment text: Request for Examination of Application

PA0302 Request for accelerated examination

Patent event date: 20170125

Patent event code: PA03022R01D

Comment text: Request for Accelerated Examination

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20170410

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20171129

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20170410

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

PJ0201 Trial against decision of rejection

Patent event date: 20180228

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20171129

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20180718

Appeal identifier: 2018101000893

Request date: 20180228

A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20180323

Application number text: 1020137034994

Filing date: 20131230

J301 Trial decision

Free format text: TRIAL NUMBER: 2018101000893; TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20180228

Effective date: 20180718

PJ1301 Trial decision

Patent event code: PJ13011S01D

Patent event date: 20180718

Comment text: Trial Decision on Objection to Decision on Refusal

Appeal kind category: Appeal against decision to decline refusal

Request date: 20180228

Decision date: 20180718

Appeal identifier: 2018101000893